This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mu, Z M
Right arrow Articles by Chang, K S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mu, Z M
Right arrow Articles by Chang, K S

 Previous Article  |  Next Article 

Mol Cell Biol. 1994 October; 14(10): 6858-6867

PML, a growth suppressor disrupted in acute promyelocytic leukemia.

Z M Mu, K V Chin, J H Liu, G Lozano and K S Chang

Division of Laboratory Medicine, University of Texas M.D. Anderson Cancer Center, Houston 77030.

ABSTRACT

The nonrandom chromosomal translocation t(15;17)(q22;q21) in acute promyelocytic leukemia (APL) juxtaposes the genes for retinoic acid receptor alpha (RAR alpha) and the putative zinc finger transcription factor PML. The breakpoint site encodes fusion protein PML-RAR alpha, which is able to form a heterodimer with PML. It was hypothesized that PML-RAR alpha is a dominant negative inhibitor of PML. Inactivation of PML function in APL may play a critical role in APL pathogenesis. Our results demonstrated that PML, but not PML-RAR alpha, is a growth suppressor. This is supported by the following findings: (i) PML suppressed anchorage-independent growth of APL-derived NB4 cells on soft agar and tumorigenicity in nude mice, (ii) PML suppressed the oncogenic transformation of rat embryo fibroblasts by cooperative oncogenes, and (iii) PML suppressed transformation of NIH 3T3 cells by the activated neu oncogene. Cotransfection of PML with PML-RAR alpha resulted in a significant reduction in PML's transformation suppressor function in vivo, indicating that the fusion protein can be a dominant negative inhibitor of PML function in APL cells. This observation was further supported by the finding that cotransfection of PML and PML-RAR alpha resulted in altered normal cellular localization of PML. Our results also demonstrated that PML, but not PML-RAR alpha, is a promoter-specific transcription suppressor. Therefore, we hypothesized that disruption of the PML gene, a growth or transformation suppressor, by the t(15;17) translocation in APL is one of the critical events in leukemogenesis.


Mol Cell Biol. 1994 October; 14(10): 6858-6867




This article has been cited by other articles:

  • Wu, Q., Hu, H., Lan, J., Emenari, C., Wang, Z., Chang, K.-s., Huang, H., Yao, X. (2009). PML3 Orchestrates the Nuclear Dynamics and Function of TIP60. J. Biol. Chem. 284: 8747-8759 [Abstract] [Full Text]  
  • Hayakawa, F., Abe, A., Kitabayashi, I., Pandolfi, P. P., Naoe, T. (2008). Acetylation of PML Is Involved in Histone Deacetylase Inhibitor-mediated Apoptosis. J. Biol. Chem. 283: 24420-24425 [Abstract] [Full Text]  
  • Weidtkamp-Peters, S., Lenser, T., Negorev, D., Gerstner, N., Hofmann, T. G., Schwanitz, G., Hoischen, C., Maul, G., Dittrich, P., Hemmerich, P. (2008). Dynamics of component exchange at PML nuclear bodies. J. Cell Sci. 121: 2731-2743 [Abstract] [Full Text]  
  • Shimada, N., Shinagawa, T., Ishii, S. (2008). Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein.. GENES CELLS 13: 245-254 [Abstract] [Full Text]  
  • Kim, T.-K., Lee, J.-S., Oh, S.-Y., Jin, X., Choi, Y.-J., Lee, T.-H., Lee, E. h., Choi, Y.-K., You, S., Chung, Y. G., Lee, J.-B., DePinho, R. A., Chin, L., Kim, H. (2007). Direct Transcriptional Activation of Promyelocytic Leukemia Protein by IFN Regulatory Factor 3 Induces the p53-Dependent Growth Inhibition of Cancer Cells. Cancer Res. 67: 11133-11140 [Abstract] [Full Text]  
  • Lee, H.-R., Kim, D.-J., Lee, J.-M., Choi, C. Y., Ahn, B.-Y., Hayward, G. S., Ahn, J.-H. (2004). Ability of the Human Cytomegalovirus IE1 Protein To Modulate Sumoylation of PML Correlates with Its Functional Activities in Transcriptional Regulation and Infectivity in Cultured Fibroblast Cells. J. Virol. 78: 6527-6542 [Abstract] [Full Text]  
  • Tashiro, S., Muto, A., Tanimoto, K., Tsuchiya, H., Suzuki, H., Hoshino, H., Yoshida, M., Walter, J., Igarashi, K. (2004). Repression of PML Nuclear Body-Associated Transcription by Oxidative Stress-Activated Bach2. Mol. Cell. Biol. 24: 3473-3484 [Abstract] [Full Text]  
  • Khan, M. M., Nomura, T., Chiba, T., Tanaka, K., Yoshida, H., Mori, K., Ishii, S. (2004). The Fusion Oncoprotein PML-RAR{alpha} Induces Endoplasmic Reticulum (ER)-associated Degradation of N-CoR and ER Stress. J. Biol. Chem. 279: 11814-11824 [Abstract] [Full Text]  
  • Lalonde, J.-P., Lim, R., Ingley, E., Tilbrook, P. A., Thompson, M. J., McCulloch, R., Beaumont, J. G, Wicking, C., Eyre, H. J., Sutherland, G. R., Howe, K., Solomon, E., Williams, J. H., Klinken, S. P. (2004). HLS5, a Novel RBCC (Ring Finger, B Box, Coiled-coil) Family Member Isolated from a Hemopoietic Lineage Switch, Is a Candidate Tumor Suppressor. J. Biol. Chem. 279: 8181-8189 [Abstract] [Full Text]  
  • Dmitrovsky, E. (2004). Tissue Microarrays for Hypothesis Generation. JNCI J Natl Cancer Inst 96: 248-249 [Full Text]  
  • Center, D. M., Cruikshank, W. W., Zhang, Y. (2004). Nuclear Pro-IL-16 Regulation of T Cell Proliferation: p27KIP1-Dependent G0/G1 Arrest Mediated by Inhibition of Skp2 Transcription. J. Immunol. 172: 1654-1660 [Abstract] [Full Text]  
  • Kurki, S., Latonen, L., Laiho, M. (2003). Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. J. Cell Sci. 116: 3917-3925 [Abstract] [Full Text]  
  • Bagutti, C., Forro, G., Ferralli, J., Rubin, B., Chiquet-Ehrismann, R. (2003). The intracellular domain of teneurin-2 has a nuclear function and represses zic-1-mediated transcription. J. Cell Sci. 116: 2957-2966 [Abstract] [Full Text]  
  • Xu, Z.-X., Timanova-Atanasova, A., Zhao, R.-X., Chang, K.-S. (2003). PML Colocalizes with and Stabilizes the DNA Damage Response Protein TopBP1. Mol. Cell. Biol. 23: 4247-4256 [Abstract] [Full Text]  
  • Kawasaki, A., Matsumura, I., Kataoka, Y., Takigawa, E., Nakajima, K., Kanakura, Y. (2003). Opposing effects of PML and PML/RARalpha on STAT3 activity. Blood 101: 3668-3673 [Abstract] [Full Text]  
  • Wu, W.-S., Xu, Z.-X., Hittelman, W. N., Salomoni, P., Pandolfi, P. P., Chang, K.-S. (2003). Promyelocytic Leukemia Protein Sensitizes Tumor Necrosis Factor alpha -Induced Apoptosis by Inhibiting the NF-kappa B Survival Pathway. J. Biol. Chem. 278: 12294-12304 [Abstract] [Full Text]  
  • Wu, W.-S., Xu, Z.-X., Chang, K.-S. (2002). The Promyelocytic Leukemia Protein Represses A20-mediated Transcription. J. Biol. Chem. 277: 31734-31739 [Abstract] [Full Text]  
  • Lopez, P., Jacob, R. J., Roizman, B. (2002). Overexpression of Promyelocytic Leukemia Protein Precludes the Dispersal of ND10 Structures and Has No Effect on Accumulation of Infectious Herpes Simplex Virus 1 or Its Proteins. J. Virol. 76: 9355-9367 [Abstract] [Full Text]  
  • Fuchsova, B., Novak, P., Kafkova, J., Hozak, P. (2002). Nuclear DNA helicase II is recruited to IFN-{alpha}-activated transcription sites at PML nuclear bodies. JCB 158: 463-473 [Abstract] [Full Text]  
  • Miller, W. H. Jr., Schipper, H. M., Lee, J. S., Singer, J., Waxman, S. (2002). Mechanisms of Action of Arsenic Trioxide. Cancer Res. 62: 3893-3903 [Abstract] [Full Text]  
  • Slack, J. L., Waxman, S., Tricot, G., Tallman, M. S., Bloomfield, C. D. (2002). Advances in the Management of Acute Promyelocytic Leukemia and Other Hematologic Malignancies with Arsenic Trioxide. The Oncologist 7: 1-13 [Abstract] [Full Text]  
  • Bonilla, W. V., Pinschewer, D. D., Klenerman, P., Rousson, V., Gaboli, M., Pandolfi, P. P., Zinkernagel, R. M., Salvato, M. S., Hengartner, H. (2002). Effects of Promyelocytic Leukemia Protein on Virus-Host Balance. J. Virol. 76: 3810-3818 [Abstract] [Full Text]  
  • Eidson, K. M., Hobbs, W. E., Manning, B. J., Carlson, P., DeLuca, N. A. (2002). Expression of Herpes Simplex Virus ICP0 Inhibits the Induction of Interferon-Stimulated Genes by Viral Infection. J. Virol. 76: 2180-2191 [Abstract] [Full Text]  
  • Khan, M. M., Nomura, T., Kim, H., Kaul, S. C., Wadhwa, R., Zhong, S., Paolo Pandolfi, P., Ishii, S. (2001). PML-RARalpha Alleviates the Transcriptional Repression Mediated by Tumor Suppressor Rb. J. Biol. Chem. 276: 43491-43494 [Abstract] [Full Text]  
  • Bischof, O., Kim, S.-H., Irving, J., Beresten, S., Ellis, N. A., Campisi, J. (2001). Regulation and Localization of the Bloom Syndrome Protein in Response to DNA Damage. JCB 153: 367-380 [Abstract] [Full Text]  
  • Hobbs, W. E., Brough, D. E., Kovesdi, I., DeLuca, N. A. (2001). Efficient Activation of Viral Genomes by Levels of Herpes Simplex Virus ICP0 Insufficient To Affect Cellular Gene Expression or Cell Survival. J. Virol. 75: 3391-3403 [Abstract] [Full Text]  
  • Wu, W.-S., Vallian, S., Seto, E., Yang, W.-M., Edmondson, D., Roth, S., Chang, K.-S. (2001). The Growth Suppressor PML Represses Transcription by Functionally and Physically Interacting with Histone Deacetylases. Mol. Cell. Biol. 21: 2259-2268 [Abstract] [Full Text]  
  • Burkham, J., Coen, D. M., Hwang, C. B. C., Weller, S. K. (2001). Interactions of Herpes Simplex Virus Type 1 with ND10 and Recruitment of PML to Replication Compartments. J. Virol. 75: 2353-2367 [Abstract] [Full Text]  
  • Rego, E. M., Wang, Z.-G., Peruzzi, D., He, L.-Z., Cordon-Cardo, C., Pandolfi, P. P. (2001). Role of Promyelocytic Leukemia (Pml) Protein in Tumor Suppression. JEM 193: 521-530 [Abstract] [Full Text]  
  • Halonen, M., Pelto–Huikko, M., Eskelin, P., Peltonen, L., Ulmanen, I., Kolmer, M. (2001). Subcellular Location and Expression Pattern of Autoimmune Regulator (Aire), the Mouse Orthologue for Human Gene Defective in Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED). J. Histochem. Cytochem. 49: 197-208 [Abstract] [Full Text]  
  • Negorev, D, Ishov, A., Maul, G. (2001). Evidence for separate ND10-binding and homo-oligomerization domains of Sp100. J. Cell Sci. 114: 59-68 [Abstract]  
  • Tsuzuki, S., Towatari, M., Saito, H., Enver, T. (2000). Potentiation of GATA-2 Activity through Interactions with the Promyelocytic Leukemia Protein (PML) and the t(15;17)-Generated PML-Retinoic Acid Receptor alpha Oncoprotein. Mol. Cell. Biol. 20: 6276-6286 [Abstract] [Full Text]  
  • Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C., Lowe, S. W. (2000). PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14: 2015-2027 [Abstract] [Full Text]  
  • Grimwade, D., Biondi, A., Mozziconacci, M.-J., Hagemeijer, A., Berger, R., Neat, M., Howe, K., Dastugue, N., Jansen, J., Radford-Weiss, I., Coco, F. L., Lessard, M., Hernandez, J.-M., Delabesse, E., Head, D., Liso, V., Sainty, D., Flandrin, G., Solomon, E., Birg, F., Lafage-Pochitaloff, M. (2000). Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Blood 96: 1297-1308 [Abstract] [Full Text]  
  • Liu, T.-X., Zhang, J.-W., Tao, J., Zhang, R.-B., Zhang, Q.-H., Zhao, C.-J., Tong, J.-H., Lanotte, M., Waxman, S., Chen, S.-J., Mao, M., Hu, G.-X., Zhu, L., Chen, Z. (2000). Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood 96: 1496-1504 [Abstract] [Full Text]  
  • Bell, P., Brazas, R., Ganem, D., Maul, G. G. (2000). Hepatitis Delta Virus Replication Generates Complexes of Large Hepatitis Delta Antigen and Antigenomic RNA That Affiliate with and Alter Nuclear Domain 10. J. Virol. 74: 5329-5336 [Abstract] [Full Text]  
  • Redner, R. L., Chen, J. D., Rush, E. A., Li, H., Pollock, S. L. (2000). The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties. Blood 95: 2683-2690 [Abstract] [Full Text]  
  • Bertho, N., Drenou, B., Laupeze, B., Berre, C. L., Amiot, L., Grosset, J.-M., Fardel, O., Charron, D., Mooney, N., Fauchet, R. (2000). HLA-DR-Mediated Apoptosis Susceptibility Discriminates Differentiation Stages of Dendritic/Monocytic APC. J. Immunol. 164: 2379-2385 [Abstract] [Full Text]  
  • Kogan, S. C., Hong, S.-h., Shultz, D. B., Privalsky, M. L., Bishop, J. M. (2000). Leukemia initiated by PMLRARalpha : the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. Blood 95: 1541-1550 [Abstract] [Full Text]  
  • Zhu, J., Gianni, M., Kopf, E., Honore, N., Chelbi-Alix, M., Koken, M., Quignon, F., Rochette-Egly, C., de The, H. (1999). Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha ) and oncogenic RARalpha fusion proteins. Proc. Natl. Acad. Sci. USA 96: 14807-14812 [Abstract] [Full Text]  
  • Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T.H., Strauss, J. F. III, Maul, G. G. (1999). Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1. JCB 147: 221-234 [Abstract] [Full Text]  
  • Le, X.-F., Groner, Y., Kornblau, S. M., Gu, Y., Hittelman, W. N., Levanon, D., Mehta, K., Arlinghaus, R. B., Chang, K.-S. (1999). Regulation of AML2/CBFA3 in Hematopoietic Cells through the Retinoic Acid Receptor alpha -Dependent Signaling Pathway. J. Biol. Chem. 274: 21651-21658 [Abstract] [Full Text]  
  • Du, C., Redner, R. L., Cooke, M. P., Lavau, C. (1999). Overexpression of Wild-Type Retinoic Acid Receptor alpha (RARalpha ) Recapitulates Retinoic Acid-Sensitive Transformation of Primary Myeloid Progenitors by Acute Promyelocytic Leukemia RARalpha -Fusion Genes. Blood 94: 793-802 [Abstract] [Full Text]  
  • Coco, F. L., Diverio, D., Falini, B., Biondi, A., Nervi, C., Pelicci, P. G. (1999). Genetic Diagnosis and Molecular Monitoring in the Management of Acute Promyelocytic Leukemia. Blood 94: 12-22 [Full Text]  
  • Melnick, A., Licht, J. D. (1999). Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia. Blood 93: 3167-3215 [Full Text]  
  • Zhu, X.-H., Shen, Y.-L., Jing, Y.-k., Cai, X., Jia, P.-M., Huang, Y., Tang, W., Shi, G.-Y., Sun, Y.-P., Dai, J., Wang, Z.-Y., Chen, S.-J., Zhang, T.-D., Waxman, S., Chen, Z., Chen, G.-Q. (1999). Apoptosis and Growth Inhibition in Malignant Lymphocytes After Treatment With Arsenic Trioxide at Clinically Achievable Concentrations. JNCI J Natl Cancer Inst 91: 772-778 [Abstract] [Full Text]  
  • Sternsdorf, T., Jensen, K., Reich, B., Will, H. (1999). The Nuclear Dot Protein Sp100, Characterization of Domains Necessary for Dimerization, Subcellular Localization, and Modification by Small Ubiquitin-like Modifiers. J. Biol. Chem. 274: 12555-12566 [Abstract] [Full Text]  
  • Lallemand-Breitenbach, V., Guillemin, M.-C., Janin, A., Daniel, M.-T., Degos, L., Kogan, S. C., Michael Bishop, J., de The, H. (1999). Retinoic Acid and Arsenic Synergize to Eradicate Leukemic Cells in a Mouse Model of Acute Promyelocytic Leukemia. JEM 189: 1043-1052 [Abstract] [Full Text]  
  • Nevels, M., Täuber, B., Kremmer, E., Spruss, T., Wolf, H., Dobner, T. (1999). Transforming Potential of the Adenovirus Type 5 E4orf3 Protein. J. Virol. 73: 1591-1600 [Abstract] [Full Text]  
  • Mologni, L., Ponzanelli, I., Bresciani, F., Sardiello, G., Bergamaschi, D., Gianni, M., Reichert, U., Rambaldi, A., Terao, M., Garattini, E. (1999). The Novel Synthetic Retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid (CD437) Causes Apoptosis in Acute Promyelocytic Leukemia Cells Through Rapid Activation of Caspases. Blood 93: 1045-1061 [Abstract] [Full Text]  
  • Everett, R., Lomonte, P, Sternsdorf, T, van Driel, R, Orr, A (1999). Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112: 4581-4588 [Abstract]  
  • Everett, R., Earnshaw, W., Pluta, A., Sternsdorf, T, Ainsztein, A., Carmena, M, Ruchaud, S, Hsu, W., Orr, A (1999). A dynamic connection between centromeres and ND10 proteins. J. Cell Sci. 112: 3443-3454 [Abstract]  
  • Guldner, H., Szostecki, C, Schroder, P, Matschl, U, Jensen, K, Luders, C, Will, H, Sternsdorf, T (1999). Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif. J. Cell Sci. 112: 733-747 [Abstract]  
  • Duprez, E, Saurin, A., Desterro, J., Lallemand-Breitenbach, V, Howe, K, Boddy, M., Solomon, E, de The, H, Hay, R., Freemont, P. (1999). SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J. Cell Sci. 112: 381-393 [Abstract]  
  • Vallian, S., Chin, K.-V., Chang, K.-S. (1998). The Promyelocytic Leukemia Protein Interacts with Sp1 and Inhibits Its Transactivation of the Epidermal Growth Factor Receptor Promoter. Mol. Cell. Biol. 18: 7147-7156 [Abstract] [Full Text]  
  • Burkham, J., Coen, D. M., Weller, S. K. (1998). ND10 Protein PML Is Recruited to Herpes Simplex Virus Type 1 Prereplicative Sites and Replication Compartments in the Presence of Viral DNA Polymerase. J. Virol. 72: 10100-10107 [Abstract] [Full Text]  
  • Liu, H.-L. C., Golder-Novoselsky, E., Seto, M. H., Webster, L., McClary, J., Zajchowski, D. A. (1998). The Novel Estrogen-Responsive B Box Protein (EBBP) Gene Is Tamoxifen Regulated in Cells Expressing an Estrogen Receptor DNA-Binding Domain Mutant. Mol. Endocrinol. 12: 1733-1748 [Abstract] [Full Text]  
  • Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T., Yeh, E. T. H. (1998). Identification of Three Major Sentrinization Sites in PML. J. Biol. Chem. 273: 26675-26682 [Abstract] [Full Text]  
  • Nervi, C., Ferrara, F. F., Fanelli, M., Rippo, M. R., Tomassini, B., Ferrucci, P. F., Ruthardt, M., Gelmetti, V., Gambacorti-Passerini, C., Diverio, D., Grignani, F., Pelicci, P. G., Testi, R. (1998). Caspases Mediate Retinoic Acid-Induced Degradation of the Acute Promyelocytic Leukemia PML/RARalpha Fusion Protein. Blood 92: 2244-2251 [Abstract] [Full Text]  
  • Shaknovich, R., Yeyati, P. L., Ivins, S., Melnick, A., Lempert, C., Waxman, S., Zelent, A., Licht, J. D. (1998). The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis. Mol. Cell. Biol. 18: 5533-5545 [Abstract] [Full Text]  
  • Ahn, J.-H., Brignole, E. J. III, Hayward, G. S. (1998). Disruption of PML Subnuclear Domains by the Acidic IE1 Protein of Human Cytomegalovirus Is Mediated through Interaction with PML and May Modulate a RING Finger-Dependent Cryptic Transactivator Function of PML. Mol. Cell. Biol. 18: 4899-4913 [Abstract] [Full Text]  
  • Lehming, N., Le Saux, A., Schuller, J., Ptashne, M. (1998). Chromatin components as part of a putative transcriptional repressing complex. Proc. Natl. Acad. Sci. USA 95: 7322-7326 [Abstract] [Full Text]  
  • Gianni, M., Koken, M. H.M., Chelbi-Alix, M. K., Benoit, G., Lanotte, M., Chen, Z., de The, H. (1998). Combined Arsenic and Retinoic Acid Treatment Enhances Differentiation and Apoptosis in Arsenic-Resistant NB4 Cells. Blood 91: 4300-4310 [Abstract] [Full Text]  
  • Borden, K. L. B., CampbellDwyer, E. J., Carlile, G. W., Djavani, M., Salvato, M. S. (1998). Two RING Finger Proteins, the Oncoprotein PML and the Arenavirus Z Protein, Colocalize with the Nuclear Fraction of the Ribosomal P Proteins. J. Virol. 72: 3819-3826 [Abstract] [Full Text]  
  • LaMorte, V. J., Dyck, J. A., Ochs, R. L., Evans, R. M. (1998). Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA 95: 4991-4996 [Abstract] [Full Text]  
  • Frank, D. J., Roth, M. B. (1998). ncl-1 Is Required for the Regulation of Cell Size and Ribosomal RNA Synthesis in Caenorhabditis elegans. JCB 140: 1321-1329 [Abstract] [Full Text]  
  • Gang Wang, Z., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., Grosveld, F., Paolo Pandolfi, P. (1998). Role of PML in Cell Growth and the Retinoic Acid Pathway. Science 279: 1547-1551 [Abstract] [Full Text]  
  • Kamitani, T., Nguyen, H. P., Kito, K., Fukuda-Kamitani, T., Yeh, E. T. H. (1998). Covalent Modification of PML by the Sentrin Family of Ubiquitin-like Proteins. J. Biol. Chem. 273: 3117-3120 [Abstract] [Full Text]  
  • Chelbi-Alix, M. K., Quignon, F., Pelicano, L., Koken, M. H. M., de The, H. (1998). Resistance to Virus Infection Conferred by the Interferon-Induced Promyelocytic Leukemia Protein. J. Virol. 72: 1043-1051 [Abstract] [Full Text]  
  • Alcalay, M., Tomassoni, L., Colombo, E., Stoldt, S., Grignani, F., Fagioli, M., Szekely, L., Helin, K., Pelicci, P. G. (1998). The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein. Mol. Cell. Biol. 18: 1084-1093 [Abstract] [Full Text]  
  • Sternsdorf, T., Jensen, K., Will, H. (1997). Evidence for Covalent Modification of the Nuclear Dot-associated Proteins PML and Sp100 by PIC1/SUMO-1. JCB 139: 1621-1634 [Abstract] [Full Text]  
  • Grimwade, D., Gorman, P., Duprez, E., Howe, K., Langabeer, S., Oliver, F., Walker, H., Culligan, D., Waters, J., Pomfret, M., Goldstone, A., Burnett, A., Freemont, P., Sheer, D., Solomon, E. (1997). Characterization of Cryptic Rearrangements and Variant Translocations in Acute Promyelocytic Leukemia. Blood 90: 4876-4885 [Abstract] [Full Text]  
  • Ferrucci, P. F., Grignani, F., Pearson, M., Fagioli, M., Nicoletti, I., Pelicci, P. G. (1997). Cell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein. Proc. Natl. Acad. Sci. USA 94: 10901-10906 [Abstract] [Full Text]  
  • Koken, M. H. M., Reid, A., Quignon, F., Chelbi-Alix, M. K., Davies, J. M., Kabarowski, J. H. S., Zhu, J., Dong, S., Chen, S.-J., Chen, Z., Tan, C. C., Licht, J., Waxman, S., de The, H., Zelent, A. (1997). Leukemia-associated retinoic acid receptor alpha  fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc. Natl. Acad. Sci. USA 94: 10255-10260 [Abstract] [Full Text]  
  • Gongora, C., David, G., Pintard, L., Tissot, C., Hua, T. D., Dejean, A., Mechti, N. (1997). Molecular Cloning of a New Interferon-induced PML Nuclear Body-associated Protein. J. Biol. Chem. 272: 19457-19463 [Abstract] [Full Text]  
  • Tenen, D. G., Hromas, R., Licht, J. D., Zhang, D.-E. (1997). Transcription Factors, Normal Myeloid Development, and Leukemia. Blood 90: 489-519 [Full Text]  
  • Ishov, A. M., Stenberg, R. M., Maul, G. G. (1997). Human Cytomegalovirus Immediate Early Interaction with Host Nuclear Structures: Definition of an Immediate Transcript Environment. JCB 138: 5-16 [Abstract] [Full Text]  
  • He, L.-Z., Tribioli, C., Rivi, R., Peruzzi, D., Pelicci, P. G., Soares, V., Cattoretti, G., Pandolfi, P. P. (1997). Acute leukemia with promyelocytic features in PML/RARalpha  transgenic mice. Proc. Natl. Acad. Sci. USA 94: 5302-5307 [Abstract] [Full Text]  
  • Zhu, J., Koken, M. H. M., Quignon, F., Chelbi-Alix, M. K., Degos, L., Wang, Z. Y., Chen, Z., de The, H. (1997). Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94: 3978-3983 [Abstract] [Full Text]  
  • Grisolano, J. L., Wesselschmidt, R. L., Pelicci, P. G., Ley, T. J. (1997). Altered Myeloid Development and Acute Leukemia in Transgenic Mice Expressing PML-RARalpha Under Control of Cathepsin G Regulatory Sequences. Blood 89: 376-387 [Abstract] [Full Text]  
  • Grotzinger, T., Jensen, K., Will, H. (1996). The Interferon (IFN)-stimulated Gene Sp100 Promoter Contains an IFN-gamma Activation Site and an Imperfect IFN-stimulated Response Element Which Mediate Type I IFN Inducibility. J. Biol. Chem. 271: 25253-25260 [Abstract] [Full Text]  
  • Le, X.-F., Yang, P., Chang, K.-S. (1996). Analysis of the Growth and Transformation Suppressor Domains of Promyelocytic Leukemia Gene, PML. J. Biol. Chem. 271: 130-135 [Abstract] [Full Text]  
  • Chatterjee, T. K., Fisher, R. A. (2000). Novel Alternative Splicing and Nuclear Localization of Human RGS12 Gene Products. J. Biol. Chem. 275: 29660-29671 [Abstract] [Full Text]